US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 990.680
  • -7.550-0.76%
Close Oct 18 16:00 ET
  • 990.680
  • 0.0000.00%
Post 20:01 ET
109.21BMarket Cap26.23P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
9.87%9.81B
17.41%10.52B
40.07%10.84B
40.07%10.84B
41.19%9.91B
17.99%8.93B
27.08%8.96B
35.96%7.74B
35.96%7.74B
21.32%7.02B
-Cash and cash equivalents
-0.85%1.92B
-33.56%2.6B
-12.10%2.73B
-12.10%2.73B
-38.35%2.15B
-42.94%1.94B
17.05%3.92B
7.63%3.11B
7.63%3.11B
1.72%3.49B
-Short-term investments
12.84%7.89B
56.99%7.92B
75.02%8.11B
75.02%8.11B
119.84%7.76B
67.59%6.99B
36.13%5.04B
65.05%4.64B
65.05%4.64B
49.90%3.53B
Receivables
11.63%5.72B
2.02%5.22B
6.35%5.67B
6.35%5.67B
0.65%5.58B
-0.78%5.12B
5.78%5.12B
-11.73%5.33B
-11.73%5.33B
1.77%5.55B
-Accounts receivable
11.63%5.72B
2.02%5.22B
6.35%5.67B
6.35%5.67B
0.65%5.58B
-0.78%5.12B
5.78%5.12B
-11.73%5.33B
-11.73%5.33B
1.77%5.55B
Inventory
14.59%2.87B
11.97%2.71B
7.44%2.58B
7.44%2.58B
6.21%2.56B
13.04%2.51B
21.75%2.42B
23.09%2.4B
23.09%2.4B
17.45%2.41B
Restricted cash
----
----
----
----
----
--5.5M
----
----
----
----
Other current assets
89.00%681.9M
2.14%414.9M
-5.98%386.6M
-5.98%386.6M
28.74%574.7M
-38.18%360.8M
-4.40%406.2M
23.71%411.2M
23.71%411.2M
-7.39%446.4M
Total current assets
12.76%19.08B
11.60%18.87B
22.63%19.48B
22.63%19.48B
20.78%18.63B
8.97%16.92B
18.20%16.91B
13.34%15.88B
13.34%15.88B
12.00%15.43B
Non current assets
Net PPE
9.77%4.31B
8.88%4.23B
10.19%4.15B
10.19%4.15B
8.15%4.01B
7.83%3.92B
9.12%3.88B
8.06%3.76B
8.06%3.76B
9.09%3.7B
-Gross PPE
----
----
12.76%6.13B
12.76%6.13B
----
----
----
11.31%5.43B
11.31%5.43B
----
-Accumulated depreciation
----
----
-18.55%-1.98B
-18.55%-1.98B
----
----
----
-19.39%-1.67B
-19.39%-1.67B
----
Goodwill and other intangible assets
15.66%1.1B
14.00%1.06B
13.45%1.04B
13.45%1.04B
26.50%1.02B
--953M
--928.7M
13,564.18%915.5M
13,564.18%915.5M
--804.1M
-Other intangible assets
----
----
13.45%1.04B
13.45%1.04B
----
----
----
--915.5M
--915.5M
----
Investments and advances
22.05%7.72B
15.04%6.98B
-18.13%5.4B
-18.13%5.4B
-3.19%5.78B
-1.38%6.33B
-14.36%6.07B
-3.60%6.59B
-3.60%6.59B
5.99%5.97B
Non current deferred assets
34.72%2.88B
43.64%2.76B
49.41%2.58B
49.41%2.58B
59.55%2.32B
58.13%2.14B
68.81%1.92B
96.57%1.72B
96.57%1.72B
100.79%1.45B
Other non current assets
152.75%993.8M
34.50%470.2M
32.02%444.1M
32.02%444.1M
28.01%409.9M
45.68%393.2M
33.44%349.6M
55.67%336.4M
55.67%336.4M
119.47%320.2M
Total non current assets
23.81%17.01B
17.85%15.5B
2.03%13.6B
2.03%13.6B
10.44%13.53B
17.63%13.73B
9.20%13.15B
16.73%13.33B
16.73%13.33B
23.78%12.25B
Total assets
17.71%36.09B
14.34%34.37B
13.23%33.08B
13.23%33.08B
16.21%32.16B
12.69%30.66B
14.08%30.06B
14.86%29.21B
14.86%29.21B
16.92%27.68B
Liabilities
Current liabilities
Payables
2.63%561.7M
11.98%671.3M
2.95%606.6M
2.95%606.6M
0.19%536.6M
2.45%547.3M
27.47%599.5M
-49.97%589.2M
-49.97%589.2M
25.43%535.6M
-accounts payable
2.63%561.7M
11.98%671.3M
2.95%606.6M
2.95%606.6M
0.19%536.6M
2.45%547.3M
27.47%599.5M
4.47%589.2M
4.47%589.2M
25.43%535.6M
Current accrued expenses
8.50%2.36B
15.36%2.39B
13.68%2.36B
13.68%2.36B
47.22%2.64B
12.55%2.18B
1.38%2.07B
30.20%2.07B
30.20%2.07B
-12.84%1.8B
-Current capital lease obligation
----
----
----
----
----
----
----
----
----
--0
Current deferred liabilities
53.77%586M
21.21%516.7M
-3.98%458.9M
-3.98%458.9M
-23.74%417.3M
-32.70%381.1M
-13.23%426.3M
8.12%477.9M
8.12%477.9M
7.76%547.2M
Current liabilities
13.02%3.51B
15.51%3.58B
8.98%3.42B
8.98%3.42B
24.99%3.6B
2.32%3.1B
3.08%3.1B
-20.12%3.14B
-20.12%3.14B
-22.49%2.88B
Non current liabilities
Long term debt and capital lease obligation
0.05%2.7B
0.06%2.7B
0.06%2.7B
0.06%2.7B
0.06%2.7B
0.06%2.7B
0.05%2.7B
36.43%2.7B
36.43%2.7B
36.45%2.7B
-Long term debt
0.07%1.98B
0.08%1.98B
0.08%1.98B
0.08%1.98B
0.08%1.98B
0.08%1.98B
0.07%1.98B
0.07%1.98B
0.07%1.98B
0.08%1.98B
-Long term capital lease obligation
0.00%720M
0.00%720M
0.00%720M
0.00%720M
0.00%720M
0.00%720M
0.00%720M
--720M
--720M
--720M
Non current deferred liabilities
76.94%205.6M
117.31%185.8M
81.52%126.7M
81.52%126.7M
108.49%125.3M
97.96%116.2M
155.22%85.5M
-4.77%69.8M
-4.77%69.8M
6.37%60.1M
Other non current liabilities
104.13%1.46B
34.14%908.5M
33.87%854.1M
33.87%854.1M
39.06%832.4M
-1.09%716.8M
-2.19%677.3M
-6.20%638M
-6.20%638M
-9.66%598.6M
Total non current liabilities
23.68%4.37B
9.61%3.8B
8.05%3.68B
8.05%3.68B
8.94%3.66B
1.47%3.54B
1.11%3.46B
24.72%3.41B
24.72%3.41B
24.50%3.36B
Total liabilities
18.70%7.88B
12.40%7.38B
8.50%7.11B
8.50%7.11B
16.35%7.26B
1.87%6.64B
2.03%6.56B
-1.73%6.55B
-1.73%6.55B
-2.72%6.24B
Shareholders'equity
Share capital
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
-common stock
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
17.22%29.41B
15.99%27.98B
16.96%27.26B
16.96%27.26B
18.05%26.1B
20.67%25.09B
20.97%24.12B
22.87%23.31B
22.87%23.31B
32.08%22.11B
Paid-in capital
13.12%12.32B
12.69%11.94B
14.12%11.35B
14.12%11.35B
18.21%11.25B
19.39%10.89B
21.06%10.6B
23.02%9.95B
23.02%9.95B
20.19%9.52B
Less: Treasury stock
14.36%13.46B
16.40%12.86B
21.32%12.56B
21.32%12.56B
23.78%12.27B
30.69%11.77B
28.27%11.05B
25.33%10.35B
25.33%10.35B
33.79%9.91B
Gains losses not affecting retained earnings
64.64%-69.9M
57.49%-77.2M
66.12%-80.9M
66.12%-80.9M
35.73%-176.8M
11.66%-197.7M
-6.76%-181.6M
-811.45%-238.8M
-811.45%-238.8M
-2,995.79%-275.1M
Total stockholders'equity
17.44%28.21B
14.88%26.99B
14.60%25.97B
14.60%25.97B
16.17%24.9B
16.10%24.02B
17.98%23.5B
20.75%22.66B
20.75%22.66B
24.23%21.44B
Total equity
17.44%28.21B
14.88%26.99B
14.60%25.97B
14.60%25.97B
16.17%24.9B
16.10%24.02B
17.98%23.5B
20.75%22.66B
20.75%22.66B
24.23%21.44B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 9.87%9.81B17.41%10.52B40.07%10.84B40.07%10.84B41.19%9.91B17.99%8.93B27.08%8.96B35.96%7.74B35.96%7.74B21.32%7.02B
-Cash and cash equivalents -0.85%1.92B-33.56%2.6B-12.10%2.73B-12.10%2.73B-38.35%2.15B-42.94%1.94B17.05%3.92B7.63%3.11B7.63%3.11B1.72%3.49B
-Short-term investments 12.84%7.89B56.99%7.92B75.02%8.11B75.02%8.11B119.84%7.76B67.59%6.99B36.13%5.04B65.05%4.64B65.05%4.64B49.90%3.53B
Receivables 11.63%5.72B2.02%5.22B6.35%5.67B6.35%5.67B0.65%5.58B-0.78%5.12B5.78%5.12B-11.73%5.33B-11.73%5.33B1.77%5.55B
-Accounts receivable 11.63%5.72B2.02%5.22B6.35%5.67B6.35%5.67B0.65%5.58B-0.78%5.12B5.78%5.12B-11.73%5.33B-11.73%5.33B1.77%5.55B
Inventory 14.59%2.87B11.97%2.71B7.44%2.58B7.44%2.58B6.21%2.56B13.04%2.51B21.75%2.42B23.09%2.4B23.09%2.4B17.45%2.41B
Restricted cash ----------------------5.5M----------------
Other current assets 89.00%681.9M2.14%414.9M-5.98%386.6M-5.98%386.6M28.74%574.7M-38.18%360.8M-4.40%406.2M23.71%411.2M23.71%411.2M-7.39%446.4M
Total current assets 12.76%19.08B11.60%18.87B22.63%19.48B22.63%19.48B20.78%18.63B8.97%16.92B18.20%16.91B13.34%15.88B13.34%15.88B12.00%15.43B
Non current assets
Net PPE 9.77%4.31B8.88%4.23B10.19%4.15B10.19%4.15B8.15%4.01B7.83%3.92B9.12%3.88B8.06%3.76B8.06%3.76B9.09%3.7B
-Gross PPE --------12.76%6.13B12.76%6.13B------------11.31%5.43B11.31%5.43B----
-Accumulated depreciation ---------18.55%-1.98B-18.55%-1.98B-------------19.39%-1.67B-19.39%-1.67B----
Goodwill and other intangible assets 15.66%1.1B14.00%1.06B13.45%1.04B13.45%1.04B26.50%1.02B--953M--928.7M13,564.18%915.5M13,564.18%915.5M--804.1M
-Other intangible assets --------13.45%1.04B13.45%1.04B--------------915.5M--915.5M----
Investments and advances 22.05%7.72B15.04%6.98B-18.13%5.4B-18.13%5.4B-3.19%5.78B-1.38%6.33B-14.36%6.07B-3.60%6.59B-3.60%6.59B5.99%5.97B
Non current deferred assets 34.72%2.88B43.64%2.76B49.41%2.58B49.41%2.58B59.55%2.32B58.13%2.14B68.81%1.92B96.57%1.72B96.57%1.72B100.79%1.45B
Other non current assets 152.75%993.8M34.50%470.2M32.02%444.1M32.02%444.1M28.01%409.9M45.68%393.2M33.44%349.6M55.67%336.4M55.67%336.4M119.47%320.2M
Total non current assets 23.81%17.01B17.85%15.5B2.03%13.6B2.03%13.6B10.44%13.53B17.63%13.73B9.20%13.15B16.73%13.33B16.73%13.33B23.78%12.25B
Total assets 17.71%36.09B14.34%34.37B13.23%33.08B13.23%33.08B16.21%32.16B12.69%30.66B14.08%30.06B14.86%29.21B14.86%29.21B16.92%27.68B
Liabilities
Current liabilities
Payables 2.63%561.7M11.98%671.3M2.95%606.6M2.95%606.6M0.19%536.6M2.45%547.3M27.47%599.5M-49.97%589.2M-49.97%589.2M25.43%535.6M
-accounts payable 2.63%561.7M11.98%671.3M2.95%606.6M2.95%606.6M0.19%536.6M2.45%547.3M27.47%599.5M4.47%589.2M4.47%589.2M25.43%535.6M
Current accrued expenses 8.50%2.36B15.36%2.39B13.68%2.36B13.68%2.36B47.22%2.64B12.55%2.18B1.38%2.07B30.20%2.07B30.20%2.07B-12.84%1.8B
-Current capital lease obligation --------------------------------------0
Current deferred liabilities 53.77%586M21.21%516.7M-3.98%458.9M-3.98%458.9M-23.74%417.3M-32.70%381.1M-13.23%426.3M8.12%477.9M8.12%477.9M7.76%547.2M
Current liabilities 13.02%3.51B15.51%3.58B8.98%3.42B8.98%3.42B24.99%3.6B2.32%3.1B3.08%3.1B-20.12%3.14B-20.12%3.14B-22.49%2.88B
Non current liabilities
Long term debt and capital lease obligation 0.05%2.7B0.06%2.7B0.06%2.7B0.06%2.7B0.06%2.7B0.06%2.7B0.05%2.7B36.43%2.7B36.43%2.7B36.45%2.7B
-Long term debt 0.07%1.98B0.08%1.98B0.08%1.98B0.08%1.98B0.08%1.98B0.08%1.98B0.07%1.98B0.07%1.98B0.07%1.98B0.08%1.98B
-Long term capital lease obligation 0.00%720M0.00%720M0.00%720M0.00%720M0.00%720M0.00%720M0.00%720M--720M--720M--720M
Non current deferred liabilities 76.94%205.6M117.31%185.8M81.52%126.7M81.52%126.7M108.49%125.3M97.96%116.2M155.22%85.5M-4.77%69.8M-4.77%69.8M6.37%60.1M
Other non current liabilities 104.13%1.46B34.14%908.5M33.87%854.1M33.87%854.1M39.06%832.4M-1.09%716.8M-2.19%677.3M-6.20%638M-6.20%638M-9.66%598.6M
Total non current liabilities 23.68%4.37B9.61%3.8B8.05%3.68B8.05%3.68B8.94%3.66B1.47%3.54B1.11%3.46B24.72%3.41B24.72%3.41B24.50%3.36B
Total liabilities 18.70%7.88B12.40%7.38B8.50%7.11B8.50%7.11B16.35%7.26B1.87%6.64B2.03%6.56B-1.73%6.55B-1.73%6.55B-2.72%6.24B
Shareholders'equity
Share capital 0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K
-common stock 0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings 17.22%29.41B15.99%27.98B16.96%27.26B16.96%27.26B18.05%26.1B20.67%25.09B20.97%24.12B22.87%23.31B22.87%23.31B32.08%22.11B
Paid-in capital 13.12%12.32B12.69%11.94B14.12%11.35B14.12%11.35B18.21%11.25B19.39%10.89B21.06%10.6B23.02%9.95B23.02%9.95B20.19%9.52B
Less: Treasury stock 14.36%13.46B16.40%12.86B21.32%12.56B21.32%12.56B23.78%12.27B30.69%11.77B28.27%11.05B25.33%10.35B25.33%10.35B33.79%9.91B
Gains losses not affecting retained earnings 64.64%-69.9M57.49%-77.2M66.12%-80.9M66.12%-80.9M35.73%-176.8M11.66%-197.7M-6.76%-181.6M-811.45%-238.8M-811.45%-238.8M-2,995.79%-275.1M
Total stockholders'equity 17.44%28.21B14.88%26.99B14.60%25.97B14.60%25.97B16.17%24.9B16.10%24.02B17.98%23.5B20.75%22.66B20.75%22.66B24.23%21.44B
Total equity 17.44%28.21B14.88%26.99B14.60%25.97B14.60%25.97B16.17%24.9B16.10%24.02B17.98%23.5B20.75%22.66B20.75%22.66B24.23%21.44B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Infectious Disease
Infectious Disease
Intraday0.00%